This new study identifies key contributors to mental health decline in individuals with atopic dermatitis, highlighting the ...

Joshua K. Sabari, MD, of NYU Langone Health discusses promising results for zongertinib in HER2-mutant NSCLC; the tyrosine ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

AZD0486 demonstrated encouraging safety and dose-dependent efficacy in heavily pretreated adolescent and adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL), according to ...

Nicolas Ferreyros, managing director, Community Oncology Alliance, discusses key components of health equity and social determinants of health that need to be addressed in cancer care.

Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the ...

While artificial intelligence (AI) holds promise to improve the diagnosis of melanoma, researchers of a new review outlined ...

Rachel Rohaidy, MD, of Miami Neuroscience Institute and Baptist Health, discusses how the evolving treatment landscape is ...

Financial, family, and logistical challenges often lead patients to choose ongoing therapies over stem cell transplantation, ...

Artificial intelligence (AI)–based electrocardiogram interpretation (AI-ECG) detected left ventricular systolic dysfunction ...

The FDA has removed Risk Evaluation and Mitigation Strategies (REMS) for approved chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, aiming to ease provider burden and ...

Jody Agena, PharmD, MBA, director of pharmacy operations, Virginia Cancer Specialists, discusses the various responsibilities of the pharmacist within community oncology settings.